These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 20083754

  • 1. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
    Yang R, Cheung MC, Byrne MM, Jin X, Montero AJ, Jones C, Koniaris LG.
    Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
    [Abstract] [Full Text] [Related]

  • 2. Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus?
    Solomon NL, Cheung MC, Byrne MM, Zhuge Y, Franceschi D, Livingstone AS, Koniaris LG.
    Ann Surg Oncol; 2010 Jan; 17(1):98-108. PubMed ID: 19777191
    [Abstract] [Full Text] [Related]

  • 3. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
    Greer SE, Pipas JM, Sutton JE, Zaki BI, Tsapakos M, Colacchio TA, Gibson JJ, Wiener DC, Ripple GH, Barth RJ.
    J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
    [Abstract] [Full Text] [Related]

  • 4. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy.
    Hallemeier CL, Botros M, Corsini MM, Haddock MG, Gunderson LL, Miller RC.
    Am J Clin Oncol; 2011 Dec; 34(6):567-72. PubMed ID: 21150564
    [Abstract] [Full Text] [Related]

  • 5. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY, Bentrem DJ, Ko CY, Tomlinson JS, Stewart AK, Winchester DP, Talamonti MS.
    Cancer; 2007 Sep 15; 110(6):1227-34. PubMed ID: 17654662
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH, Leder G, Formentini A, Fortnagel G, Kornmann M, Schatz M, Beger HG.
    Gan To Kagaku Ryoho; 1999 Jan 15; 26(1):10-40. PubMed ID: 9987495
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB.
    Ann Surg; 2008 Mar 15; 247(3):456-62. PubMed ID: 18376190
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
    Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG.
    Cancer; 2010 Jun 15; 116(12):2932-40. PubMed ID: 20336787
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ, van der Gaast A, Incrocci L, van Dekken H, Hermans JJ, Jeekel J, Hop WC, Kazemier G, van Eijck CH.
    Ann Surg; 2008 Dec 15; 248(6):1031-41. PubMed ID: 19092348
    [Abstract] [Full Text] [Related]

  • 12. Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?
    Cheung MC, Yang R, Byrne MM, Solorzano CC, Nakeeb A, Koniaris LG.
    Cancer; 2010 Feb 01; 116(3):723-33. PubMed ID: 19998350
    [Abstract] [Full Text] [Related]

  • 13. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
    Sa Cunha A, Rault A, Laurent C, Adhoute X, Vendrely V, Béllannée G, Brunet R, Collet D, Masson B.
    J Am Coll Surg; 2005 Sep 01; 201(3):359-65. PubMed ID: 16125068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM, Meyer JE, Sherr DL.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1128-33. PubMed ID: 18538501
    [Abstract] [Full Text] [Related]

  • 16. Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment.
    Artinyan A, Hellan M, Mojica-Manosa P, Chen YJ, Pezner R, Ellenhorn JD, Kim J.
    Cancer; 2008 Jan 01; 112(1):34-42. PubMed ID: 18000805
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.
    Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):150-5. PubMed ID: 19297105
    [Abstract] [Full Text] [Related]

  • 18. Long term survival after pancreatic resection for pancreatic adenocarcinoma.
    Ahmad NA, Lewis JD, Ginsberg GG, Haller DG, Morris JB, Williams NN, Rosato EF, Kochman ML.
    Am J Gastroenterol; 2001 Sep 01; 96(9):2609-15. PubMed ID: 11569683
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
    Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Büchler MW, European Study Group for Pancreatic Cancer.
    N Engl J Med; 2004 Mar 18; 350(12):1200-10. PubMed ID: 15028824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.